IRR
Finance
Is Everstone still hitting benchmark returns from Indostar partial exit?
Private equity firm Everstone Capital, which will cede majority ownership in non-bank lender Indostar Capital Finance Ltd, is poised to ......
Consumer
WestBridge scores benchmark returns by exiting consumer firm
Homegrown private equity firm WestBridge Capital has generated benchmark returns by selling a stake in one of its consumer-facing portfolio ......
TMT
Kaup Capital presses exit button on debut India investment with sharp haircut
Private equity firm Kaup Capital, known for its focus on the infrastructure sector, has taken a sharp haircut on its ......
Healthcare
How much did CDC Group make by paring stake in hospital chain?
CDC Group Plc, the UK government’s development finance institution, has struck a partial exit from a hospital chain in which ......
Healthcare
Temasek stares at massive haircut from Indian pharma investment
Singapore state investor Temasek Holdings is staring at a sharp loss from its nearly five-year-old investment in an Indian drugmaker ......
Manufacturing
Everstone harvests below-par returns from agrochemical bet
Private equity firm Everstone Capital has logged out completely from an agrochemical company through a buyback transaction, two people privy ......
Healthcare
Everstone eyes another quick exit from young portfolio firm
Private equity firm Everstone Capital has initiated the process to exit a relatively young portfolio company in which it had ......
Finance
PE/VC exit returns in 2019 a tad below par but match top-performing mutual funds
A handful of private equity and venture capital firms in India may have struck gold by fully exiting their investments ......
Finance
Warburg Pincus set to make stellar returns from partial exit in CAMS via IPO
Computer Age Management Services Ltd (CAMS), a technology-driven financial infrastructure and services provider to mutual funds and other financial institutions ......
Healthcare
ChrysCapital logs out of drugmaker with below-par returns
Homegrown private equity firm ChrysCapital has fully exited its more than seven-year-old investment in a pharmaceutical company with below-average returns. ChrysCapital ......